PT1715785E - Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio - Google Patents

Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio Download PDF

Info

Publication number
PT1715785E
PT1715785E PT05703127T PT05703127T PT1715785E PT 1715785 E PT1715785 E PT 1715785E PT 05703127 T PT05703127 T PT 05703127T PT 05703127 T PT05703127 T PT 05703127T PT 1715785 E PT1715785 E PT 1715785E
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
therapeutic methods
tellurium compounds
treating warts
warts
Prior art date
Application number
PT05703127T
Other languages
English (en)
Inventor
Michael Albeck
Benjamin Sredni
Original Assignee
Biomas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomas Ltd filed Critical Biomas Ltd
Publication of PT1715785E publication Critical patent/PT1715785E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT05703127T 2004-01-22 2005-01-23 Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio PT1715785E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53863504P 2004-01-22 2004-01-22

Publications (1)

Publication Number Publication Date
PT1715785E true PT1715785E (pt) 2014-06-24

Family

ID=34807203

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05703127T PT1715785E (pt) 2004-01-22 2005-01-23 Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio

Country Status (11)

Country Link
US (3) US9011933B2 (pt)
EP (1) EP1715785B1 (pt)
JP (1) JP4903057B2 (pt)
AU (1) AU2005207635B2 (pt)
CA (1) CA2553803C (pt)
DK (1) DK1715785T3 (pt)
ES (1) ES2465498T3 (pt)
NZ (1) NZ548988A (pt)
PL (1) PL1715785T3 (pt)
PT (1) PT1715785E (pt)
WO (1) WO2005069735A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9011933B2 (en) 2004-01-22 2015-04-21 Biomas Ltd. Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
WO2008013493A1 (en) * 2006-07-25 2008-01-31 Iss Immune System Stimulation Ab Topical treatment of warts
JP2010502764A (ja) 2006-09-11 2010-01-28 バイオマス リミテッド テルル含有化合物の局所製剤
CA2705944C (en) * 2007-11-23 2017-10-24 Biomas Ltd. Methods and compositions for inhibiting integrins using tellurium-containing compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102908A (en) * 1985-03-15 1992-04-07 Michael Albeck Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives
US4962207A (en) * 1985-09-30 1990-10-09 Bar-Ilan University Organic derivatives of tellurium and selenium
US4761490A (en) * 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US5093135A (en) * 1985-09-30 1992-03-03 Michael Albeck Compounds for the induction of in vivo and in vitro production of cytokines
US4764461A (en) * 1985-09-30 1988-08-16 Bar-Ilan University Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines
US4752614A (en) * 1985-09-30 1988-06-21 Bar-Ilan University Pharmaceutical compositions of tellerium and selenium compounds for the induction of in vivo and in vitro production of cytokines
US4781490A (en) * 1986-08-06 1988-11-01 Murray Jelling Method of pothole repair
US4929739A (en) * 1988-03-24 1990-05-29 Bar-Ilan University Complexes of tellurium and selenium derivatives
US5213899A (en) * 1990-12-17 1993-05-25 General Electric Company Room temperature vulcanizable silicone compositions
US6472381B1 (en) * 2001-10-12 2002-10-29 Biomas Inc. Method of treating psoriasis
US9011933B2 (en) 2004-01-22 2015-04-21 Biomas Ltd. Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
EP1791535B1 (en) * 2004-09-17 2008-07-30 BioMAS Ltd. Novel tellurium compounds and their use as immunomodulators
JP2010502764A (ja) * 2006-09-11 2010-01-28 バイオマス リミテッド テルル含有化合物の局所製剤

Also Published As

Publication number Publication date
ES2465498T3 (es) 2014-06-05
US20150224111A1 (en) 2015-08-13
EP1715785A2 (en) 2006-11-02
CA2553803C (en) 2015-08-18
CA2553803A1 (en) 2005-08-04
US9011933B2 (en) 2015-04-21
EP1715785A4 (en) 2009-07-22
JP4903057B2 (ja) 2012-03-21
WO2005069735A2 (en) 2005-08-04
EP1715785B1 (en) 2014-03-26
NZ548988A (en) 2010-04-30
AU2005207635B2 (en) 2011-05-26
WO2005069735A3 (en) 2009-04-23
US20100330201A1 (en) 2010-12-30
DK1715785T3 (da) 2014-06-30
US20170112874A1 (en) 2017-04-27
PL1715785T3 (pl) 2014-08-29
AU2005207635A1 (en) 2005-08-04
JP2007525493A (ja) 2007-09-06

Similar Documents

Publication Publication Date Title
IL177717A0 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
GB2423928B (en) Methods and compositions for treating pain
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
EP1732650A4 (en) COMPOSITION AND METHOD FOR CANCER TREATMENT
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
PL1804777T3 (pl) Kompozycja farmaceutyczna zawierająca diklofenak
IL191040A0 (en) Pharmaceutical compositions containing irinotecan and floxuridine for treatment of solid tumors
EP1773369A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PEPTIDE TREATMENT
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP1720563A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
EP1885351A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
EP2007790A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
ZA200709443B (en) Methods for the treatment of substance abuse and dependence
EP1715785A4 (en) THERAPEUTIC METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LATCHES WITH TELLURE-BASED COMPOSITIONS
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1719514A4 (en) MEDICAMENT FOR TREATING PAIN
IL176876A0 (en) Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
GB0425532D0 (en) Therapeutic compounds and methods for their preparation and use
HUP0400762A3 (en) Pharmaceutical composition for preventing or treating diabetes
AU2004901220A0 (en) Compositions and methods for treatment disease
GB0513546D0 (en) Therapeutic compounds and methods for their preparation and use
HU0400847D0 (en) Pharmaceutical composition for the treatment of diabetes